RMD
ResMed Inc
218.90$
-1.0%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 26.0% | 23.5% | 33.6% | 36.0% | 26.6% | 24.1% | 44.8% | 40.0% | 34.2% | 23.9% | 38.7% | 123.4% | 55.8% | |
| 4.8% | 4.6% | 4.6% | 4.5% | 4.4% | 4.4% | 4.0% | 5.5% | 4.3% | 4.4% | 4.8% | 16.7% | 7.7% | |
| 1.7% | 1.7% | 1.7% | 1.7% | 1.6% | 1.8% | 1.9% | 1.8% | 1.6% | 2.0% | 1.9% | 7.1% | 3.2% | |
| 2.1% | – | – | – | – | – | – | – | – | – | – | – | – | |
| -0.9% | -0.8% | 3.4% | 4.7% | -4.9% | 4.6% | 10.2% | 0.7% | 1.9% | -10.0% | 8.2% | -5.1% | -1.3% | |
| 3.7% | 2.0% | 1.9% | 2.2% | 1.6% | 1.5% | 1.8% | 2.3% | 3.2% | 2.4% | 2.4% | 10.7% | 4.7% | |
| -13.5% | -3.5% | -2.8% | -3.8% | 0.2% | -2.9% | -2.5% | -9.9% | -3.9% | -3.6% | -4.1% | -37.2% | -12.5% | |
| 6.4% | 6.1% | 5.9% | 5.8% | 6.4% | 6.1% | 6.0% | 5.8% | 6.6% | 6.2% | 6.1% | 23.9% | 10.8% | |
| 9.5% | -4.3% | -4.2% | -4.1% | -4.1% | -5.8% | -5.8% | -7.4% | -11.2% | -12.3% | -12.2% | -47.8% | -21.2% | |
| -7.3% | – | – | – | -2.4% | -0.4% | 0.0% | -0.4% | 0.0% | -0.4% | 0.0% | -0.3% | -0.2% | |
| -13.7% | -20.6% | -28.1% | -32.2% | -12.3% | -11.5% | -11.2% | -12.2% | -17.2% | -18.2% | -17.8% | -68.8% | -31.0% | |
| -1.7% | 0.1% | 2.3% | 0.0% | 15.4% | 7.5% | 31.8% | 20.5% | 13.1% | 2.3% | 17.0% | 17.7% | 12.6% | |
| 22.3% | 21.5% | 31.7% | 33.8% | 25.0% | 22.6% | 43.0% | 37.7% | 31.0% | 21.4% | 36.4% | 112.7% | 51.1% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.